No tags yet.
India possesses a huge market for medicines. A recent study stated that everyday medicines worth more than Rs. 400 crore are being bought and sold in the Indian market. With the ever-increasing population in India, it is reasonable to assume that the number of patients per year and the corresponding consumption of medicines is going to skyrocket in the coming years. Hence, it might be a great time to play on companies engaged in the manufacture of, or in some way related to, medicines or the pharma industry at large.
Reliance Pharma Fund shall be your first choice if at all you are considering to step into sector-oriented investing, precisely leveraging on pharma funds. It is a high-in-demand fund amongst those who are looking forward to crystallizing the opportunities available in the pharma industry and earn loads of returns through a slightly risky portfolio. If you are having similar thoughts, then you ought to invest through MySIPonline where you’d finish your investment process in less than 7 minutes.
However, before you get all excited and plan your next move, there are certain things that you ought to get acquainted with. Our team at MySIPonline have spotted some riveting facts about Reliance Pharma Fund (G) which shall be committed to memory by all those who are desirous of planning an investment in it.
The General Info Reliance Pharma Fund (Growth), as the name suggests, is an equity-oriented fund that primarily buys stocks in the companies engaged in the pharma industry. The fund has been operating since June 2004 and has created a good reputation for itself in the Indian market. Launched by Reliance Mutual Fund, one of the biggest asset management companies in India, it enjoys a dominating position in the market in the league of best sector-oriented funds headed towards leveraging on the pharma sector.
The Objective Like any other fund in the market, Reliance Pharma Fund (G) too strives for long-term capital appreciation and regular income, however, with a different set of strategies. While the fund follows a pure equity exposure (99.62%), it might also invest in fixed income securities to recalibrate the portfolio to earn best results as per the prevailing market conditions. This ensures that the fund is always on the course of meeting its objective and that the rate of fluctuations in its performance is reduced down to an acceptably low level.
The Performance The analysis of the past performance enables the reader, though not to the utmost accuracy, to contemplate what the future of the fund may look like. The following graph will help us understand how Reliance Pharma Fund (Growth) has performed in the past, and will also act as a navigator to its future: -
As you can see from the above chart, the fund has performed exceptionally well. While the benchmark and the peers were struggling to scramble over the wall of negative returns and land onto positive ground, Reliance Pharma Fund was enjoying the flight of high returns. This concludes that the fund indeed has the potential of earning handsome returns, plus may provide the same or even better returns in the future.
The Risk However good a fund may be, there’s always a cloud of risk hovering over it. As you can see from the table above, the returns earned by Reliance Pharma Fund G took a steep dip during the transition from 1-year period to 3-year period, and then again surged to a good height during the 5-year period. This shows that the fund is a risky venture, and thus will suit those who can stomach high risks.
So, if you plan to take advantage of the growing pharma industry, then investing in Reliance Pharma Fund can certainly open ways to success. MySIPonline will further streamline the process of investing by providing online facilities to invest in it quickly, without charging you a dime.